BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2117687)

  • 1. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
    Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD
    Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results for 149 medulloblastoma patients from one institution.
    Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult medulloblastoma: prognostic factors and patterns of relapse.
    Chan AW; Tarbell NJ; Black PM; Louis DN; Frosch MP; Ancukiewicz M; Chapman P; Loeffler JS
    Neurosurgery; 2000 Sep; 47(3):623-31; discussion 631-2. PubMed ID: 10981749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
    Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medulloblastoma in adults : A retrospective single institution analysis.
    Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
    Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of radiation therapy for medulloblastoma].
    Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
    Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
    World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastoma in adults: treatment results and prognostic factors.
    Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma: experience of a single institution.
    Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
    Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
    Tian S; Sudmeier LJ; Zhang C; Madden NA; Buchwald ZS; Shu HG; Curran WJ; Eaton BR; Esiashvili N
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28027. PubMed ID: 31571408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
    Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose craniospinal radiation therapy for medulloblastoma.
    Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
    Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
    Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
    Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
    J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.